Literature DB >> 10997941

Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices.

A B Renwick1, P S Watts, R J Edwards, P T Barton, I Guyonnet, R J Price, J M Tredger, O Pelkonen, A R Boobis, B G Lake.   

Abstract

The maintenance of the major hepatic cytochrome P450 (CYP) enzymes has been studied in precision-cut human liver slices cultured for up to 72 h in supplemented RPMI 1640 medium. The relative apoprotein levels of 11 CYP enzymes were determined using a panel of antipeptide antibodies. In addition, 7-ethoxyresorufin O-deethylase, tolbutamide methylhydroxylase, debrisoquine 4-hydroxylase, and testosterone 6beta-hydroxylase activities were determined as enzymatic markers for CYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively. There was a large variation in the rate of decline of different CYP levels with time in culture. Based on the rate of decrease, CYP enzymes could be separated into two groups, with CYP2C9, CYP2D6, CYP3A4, and CYP4A11 being relatively stable (half-lives between 70 and 104 h), compared with CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, and CYP3A5, which were relatively unstable (half-lives between 23 and 36 h). Enzyme activities decreased at rates similar to those of their corresponding apoproteins. There was also a large difference in the stability of individual CYP enzymes from different liver donors, particularly for the most rapidly declining CYP enzymes. Similar losses of CYP enzymes were found when human liver slices were cultured in supplemented Williams' medium E for 72 h, except that CYP2E1 apoprotein levels were better maintained. Because of the variable decreases of CYP enzymes, xenobiotic metabolism studies are best performed with freshly cut rather than cultured human liver slices.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997941

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects.

Authors:  Shirin Bruderer; Marc Petersen-Sylla; Margaux Boehler; Tatiana Remeňová; Atef Halabi; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

2.  Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery.

Authors:  Yoshiki Katada; Shunsaku Nakagawa; Akiko Nishimura; Yu-Ki Sato; Hiromi Taue; Katsuyuki Matsumura; Kazuhiro Yamazaki; Kenji Minakata; Ikuko Yano; Tomohiro Omura; Satoshi Imai; Atsushi Yonezawa; Yuki Sato; Takayuki Nakagawa; Kenji Minatoya; Kazuo Matsubara
Journal:  Eur J Clin Pharmacol       Date:  2018-11-21       Impact factor: 2.953

3.  Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole.

Authors:  Jeannine Chan; Tyler Oshiro; Sarah Thomas; Allyson Higa; Stephen Black; Aleksandar Todorovic; Fawzy Elbarbry; John P Harrelson
Journal:  Drug Metab Dispos       Date:  2016-02-05       Impact factor: 3.922

4.  An S-warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N-deacetylated amino acid metabolite as the primary perpetrator.

Authors:  Ken Grime; Rikard Pehrson; Pär Nordell; Michael Gillen; Wolfgang Kühn; Timothy Mant; Marie Brännström; Petter Svanberg; Barry Jones; Clive Brealey
Journal:  Br J Clin Pharmacol       Date:  2016-10-13       Impact factor: 4.335

5.  Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.

Authors:  Hélène Martin; Jean-Pierre Sarsat; Isabelle de Waziers; Chantal Housset; Pierre Balladur; Philippe Beaune; Véronique Albaladejo; Carole Lerche-Langrand
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

6.  Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Mol Pharm       Date:  2018-04-10       Impact factor: 4.939

Review 7.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

8.  Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde.

Authors:  Michael J Espiritu; Justin Chen; Jaydeep Yadav; Michael Larkin; Robert D Pelletier; Jeannine M Chan; Jeevan B Gc; Senthil Natesan; John P Harrelson
Journal:  Drug Metab Dispos       Date:  2020-08-12       Impact factor: 3.922

9.  Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics.

Authors:  Sabine U Vorrink; Shahid Ullah; Staffan Schmidt; Jatin Nandania; Vidya Velagapudi; Olof Beck; Magnus Ingelman-Sundberg; Volker M Lauschke
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

10.  Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days.

Authors:  Viktoriia Starokozhko; Suresh Vatakuti; Bauke Schievink; Marjolijn T Merema; Annika Asplund; Jane Synnergren; Anders Aspegren; Geny M M Groothuis
Journal:  Arch Toxicol       Date:  2016-10-07       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.